PhRMA-backed al­liance says it wants to 'mod­ern­ize' the 340B pro­gram. Crit­ics say the changes will on­ly lim­it ac­cess

The Al­liance to Save Amer­i­ca’s 340B Pro­gram (AS­AP 340B) is made up of a coali­tion of bio­phar­ma stake­hold­ers who last week re­leased a set of changes it thinks should be made to the dis­count pro­gram, spark­ing a re­but­tal from op­pos­ing or­ga­ni­za­tions who say the changes will on­ly lim­it ac­cess to nec­es­sary meds.

Es­tab­lished in 1992, 340B is a fed­er­al health pro­gram that re­quires phar­ma com­pa­nies to of­fer dis­counts on their drugs to hos­pi­tals that treat low-in­come pa­tients. But drug­mak­ers over the last year have claimed the pro­gram is be­ing abused by hos­pi­tals and have set their own re­stric­tions.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN